Trial Profile
Impact of Boostrix Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Feb 2024
Price :
$35
*
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 01 Oct 2020 Results of a time-series analyses assessing trends in different age-strata and in infant and maternal pertussis vaccine published in the Vaccine
- 07 May 2018 Status changed from recruiting to completed.
- 06 Jul 2017 Planned primary completion date changed from 1 Jan 2018 to 16 Apr 2018.